Enorama Pharma AB is a Swedish pharmaceutical company listed on Nasdaq First North Growth Market. We focus on development and manufacturing of consumer friendly medicated chewing gums containing well proven generic substances. We have a unique manufacturing model and a devoted staff with extensive experience from the medicated gum business.
Our ambition is to be a leading global provider of innovative medicated gums containing generic pharmaceutical substances, developed through our ChewMed® technology platform.
Our first product, a nicotine replacement gum with superior consumer properties, is available for in-licensing. The nicotine gum was registered as a pharmaceutical in Sweden in August, 2019 and market authorizations on several other relevant markets are ongoing.
- Pharma company based in Malmö, Sweden
- Develops and manufactures medicated chewing gums
- Unique compressed gum technology - ChewMed®
- CRO/CMO in Hyderabad, Indien
- B2B/Private Label
- Listed on Nasdaq First North Growth Market since 2016